Fig. 1 From: Combined intravitreal dexamethasone and bevacizumab injection for the treatment of persistent diabetic macular edema (DexaBe study): a phase I clinical studyMean intraocular pressure at baseline and during the 24 week-follow-up study period. *Indicates statistically significant change compared to baseline (p < 0.05). There was a significant increase on IOP at weeks 1, 16, 20 and 24 compared to baseline valuesBack to article page